2023/12/22 Press Release

The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs

FEF Pharmaceutical Co., Ltd. and Kyoto University are conducting a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD).

Kyoto University has released a news release regarding the initiation of the investigator-initiated clinical trial of EIM-001 which is developed by FEF Pharmaceutical Co., Ltd.

Please refer to the press release of Kyoto University Hospital for details.

News Top

Contact Us

For more information,
please feel free to contact us from below.